Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.41
0.00 (0.07%)
Sep 17, 2026, 10:14 AM EDT - Market open
Grifols Market Cap
Grifols has a market cap or net worth of $6.58 billion as of September 17, 2026. Its market cap has decreased by -3.12% in one year.
Market Cap
6.58B
Enterprise Value
19.57B
1-Year Change
-3.12%
Ranking
Category
Stock Price
$7.41
ChartMarket Cap Chart
Since June 2, 2011, Grifols's market cap has increased from $5.00B to $6.58B, an increase of 31.72%. That is a compound annual growth rate of 1.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 5.06B | -21.28% |
| Dec 31, 2025 | 6.43B | 25.67% |
| Dec 31, 2024 | 5.12B | -35.64% |
| Dec 29, 2023 | 7.95B | 36.00% |
| Dec 30, 2022 | 5.84B | -24.31% |
| Dec 31, 2021 | 7.72B | -39.10% |
| Dec 31, 2020 | 12.68B | -20.82% |
| Dec 31, 2019 | 16.01B | 26.85% |
| Dec 31, 2018 | 12.62B | -19.90% |
| Dec 29, 2017 | 15.76B | 42.63% |
| Dec 30, 2016 | 11.05B | -0.80% |
| Dec 31, 2015 | 11.14B | -4.68% |
| Dec 31, 2014 | 11.69B | -0.94% |
| Dec 31, 2013 | 11.80B | 39.30% |
| Dec 31, 2012 | 8.47B | 134.45% |
| Dec 30, 2011 | 3.61B | -27.71% |
| Jun 2, 2011 | 5.00B | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 254.11B |
| Amgen | 206.25B |
| Novo Nordisk | 191.47B |
| Gilead Sciences | 181.54B |
| Pfizer | 157.99B |
| Bristol-Myers Squibb Company | 130.94B |
| Sanofi | 104.29B |
| GSK plc | 100.17B |